Bispecific radioligands targeting prostate-specific membrane antigen and gastrin-releasing peptide receptors on the surface of prostate cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bispecific radioligands targeting prostate-specific membrane antigen and gastrin-releasing peptide receptors on the surface of prostate cancer cells

Published:2019-06-30 Issue:8 Volume:62 Page:510-522
ISSN:0362-4803
Container-title:Journal of Labelled Compounds and Radiopharmaceuticals
language:en
Short-container-title:J Label Compd Radiopharm

Author:

Liolios Christos¹^ORCID,Sachpekidis Christos²,Schäfer Martin¹,Kopka Klaus¹³

Affiliation:

1. Division of Radiopharmaceutical Chemistry; German Cancer Research Center (DKFZ); Heidelberg ]-->Germany

2. Clinical Cooperation Unit Nuclear Medicine; German Cancer Research Center (DKFZ); Heidelberg ]-->Germany

3. German Cancer Consortium (DKTK); German Cancer Research Center (DKFZ); Heidelberg ]-->Germany

Publisher

Wiley

Subject

Organic Chemistry,Spectroscopy,Drug Discovery,Radiology, Nuclear Medicine and imaging,Biochemistry,Analytical Chemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jlcr.3749/fullpdf

Reference72 articles.

1. A nomogram predicting long-term biochemical recurrence after radical prostatectomy;Suardi;Cancer,2008

2. Targeting bone metastases in prostate cancer: improving clinical outcome;Body;Nat Rev Urol,2015

3. Prostate-specific membrane antigen ligands for imaging and therapy;Eiber;J Nucl Med,2017

4. COU-AA-301 Investigators. Abiraterone and increased survival in metastatic prostate cancer;Bono;N Engl J Med,2011

5. AFFIRM Investigators. Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy;Scher;N Engl J Med,2012

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiopharmaceuticals Targeting Gastrin-Releasing Peptide Receptor for Diagnosis and Therapy of Prostate Cancer;Molecular Pharmaceutics;2024-08-06

2. Radiolabeled iron oxide nanoparticles functionalized with PSMA/BN ligands for dual-targeting of prostate cancer;Frontiers in Nuclear Medicine;2023-09-20

3. Clinical Advances and Perspectives in Targeted Radionuclide Therapy;Pharmaceutics;2023-06-14

4. Synthesis and in vitro proof-of-concept studies on bispecific iron oxide magnetic nanoparticles targeting PSMA and GRP receptors for PET/MR imaging of prostate cancer;International Journal of Pharmaceutics;2022-08

5. Radiolabeled PSMA Inhibitors;Cancers;2021-12-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3